PeptideDB

Cauloside D 12672-45-6

Cauloside D 12672-45-6

CAS No.: 12672-45-6

Cauloside D is a triterpenoid glycoside extracted from Caulophyllum robustum Max. Cauloside D exerts anti~inflammatory e
Data collection:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Cauloside D is a triterpenoid glycoside extracted from Caulophyllum robustum Max. Cauloside D exerts anti~inflammatory effects by inhibiting the expression of iNOS and pro-inflammatory cytokines.

Physicochemical Properties


Molecular Formula C53H86O22
Molecular Weight 1075.2368
Exact Mass 1074.56
CAS # 12672-45-6
PubChem CID 71586956
Appearance White to off-white solid powder
LogP -0.9
Hydrogen Bond Donor Count 13
Hydrogen Bond Acceptor Count 22
Rotatable Bond Count 12
Heavy Atom Count 75
Complexity 2060
Defined Atom Stereocenter Count 28
SMILES

C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H](O[C@H]([C@@H]([C@H]2O)O)OC[C@@H]3[C@H]([C@@H]([C@H]([C@@H](O3)OC(=O)[C@@]45CC[C@@]6(C(=CC[C@H]7[C@]6(CC[C@@H]8[C@@]7(CC[C@@H]([C@@]8(C)CO)O[C@H]9[C@@H]([C@H]([C@H](CO9)O)O)O)C)C)[C@H]4CC(CC5)(C)C)C)O)O)O)CO)O)O)O

InChi Key UEHILKCNLIKLEV-QPMMERAHSA-N
InChi Code

InChI=1S/C53H86O22/c1-23-32(57)35(60)39(64)45(70-23)74-42-27(19-54)71-43(41(66)37(42)62)69-21-28-34(59)36(61)40(65)46(72-28)75-47(67)53-16-14-48(2,3)18-25(53)24-8-9-30-49(4)12-11-31(73-44-38(63)33(58)26(56)20-68-44)50(5,22-55)29(49)10-13-52(30,7)51(24,6)15-17-53/h8,23,25-46,54-66H,9-22H2,1-7H3/t23-,25+,26-,27+,28+,29+,30+,31-,32-,33-,34+,35+,36-,37+,38+,39+,40+,41+,42+,43+,44-,45-,46-,49-,50-,51+,52+,53-/m0/s1
Chemical Name

[(2S,3R,4S,5S,6R)-6-[[(2R,3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxymethyl]-3,4,5-trihydroxyoxan-2-yl] (4aS,6aR,6aS,6bR,8aR,9R,10S,12aR,14bR)-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-10-[(2S,3R,4S,5S)-3,4,5-trihydroxyoxan-2-yl]oxy-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylate
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Note: This product requires protection from light (avoid light exposure) during transportation and storage.
Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


Targets Inhibition of inducible nitric oxide synthase (iNOS) and pro-inflammatory cytokine (TNF-α, IL-6) expression in activated microglia. [1]
ln Vitro Cauloside D (at high concentrations such as 50 μg/mL) significantly inhibited lipopolysaccharide (LPS)-induced nitric oxide (NO) generation in BV2 murine microglial cells in a dose-dependent manner. [1]
Cauloside D (at low concentrations of 1-5 μg/mL) strongly suppressed LPS-induced iNOS protein expression in BV2 cells. [1]
Cauloside D showed a relatively strong suppressing effect on the expression of the pro-inflammatory cytokines TNF-α and IL-6 in LPS-stimulated BV2 microglial cells. [1]
In a preliminary cytotoxicity test, treatment with Cauloside D (1-50 μg/mL) for 24 hours did not modulate the viability of BV2 cells. [1]
Cell Assay Nitrite Assay (Griess Reaction): BV2 microglial cells were cultured in 24-well plates. Cells were co-treated with LPS (100 ng/mL) and various concentrations of Cauloside D for 24 hours. The accumulation of nitrite, a stable oxidation product of NO, in the culture supernatant was measured. Briefly, 50 μL of supernatant was mixed with an equal volume of Griess reagent (1% sulfanilamide and 0.1% N-1-naphthylethylenediamine dihydrochloride in 5% phosphoric acid), and the absorbance was measured at 540 nm. [1]
Immunoblot Analysis (Western Blot): After treatment with LPS and Cauloside D for 24 hours, BV2 cells were washed and lysed. Protein concentrations were determined. Equal amounts of protein were separated by SDS-PAGE and transferred to a membrane. The membrane was blocked and then incubated with primary antibodies against iNOS, TNF-α, or IL-6, followed by incubation with horseradish peroxidase-conjugated secondary antibodies. Protein bands were visualized using an enhanced chemiluminescence detection kit. GAPDH was used as an internal loading control. [1]
References

[1]. Anti-Inflammatory Effect of Triterpene Saponins Isolated from Blue Cohosh (Caulophyllum thalictroides). Evid Based Complement Alternat Med. 2012;2012:798192.

Additional Infomation Unii-4N5Z068gaz has been reported in Caulophyllum thalictroides, Pulsatilla campanella, and other organisms with data available.
See also: Caulophyllum robustum Root (part of).
Cauloside D is a triterpene saponin constituent isolated from the roots and rhizomes of blue cohosh (Caulophyllum thalictroides). [1]
Cauloside D has three sugar moieties attached to a COO- group. The literature suggests that intracellular esterases might detach these sugars, potentially converting Cauloside D into Cauloside A within cells. [1]
Among the tested Caulosides A-D, Cauloside D (along with Cauloside A) showed a relatively stronger suppressing effect on LPS-induced TNF-α expression in microglia. [1]

Solubility Data


Solubility (In Vitro) DMSO : ~100 mg/mL (~89.50 mM)
Solubility (In Vivo) Solubility in Formulation 1: ≥ 2.5 mg/mL (2.24 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL.
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.

Solubility in Formulation 2: ≥ 2.5 mg/mL (2.24 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.

Solubility in Formulation 3: ≥ 2.5 mg/mL (2.24 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 0.9300 mL 4.6501 mL 9.3002 mL
5 mM 0.1860 mL 0.9300 mL 1.8600 mL
10 mM 0.0930 mL 0.4650 mL 0.9300 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.